Assessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analys...

por Weinstock-Guttman, Bianca, Medin, Jennie, Khan, Nasreen, Korn, Jonathan R., Lathi, Ellen, Silversteen, Jason, Calkwood, Jonathan, Silva, Diego, Zivadinov, Robert
Publicado 2017

Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc anal...

por Calkwood, Jonathan, Cree, Bruce, Crayton, Heidi, Kantor, Daniel, Steingo, Brian, Barbato, Luigi, Hashmonay, Ron, Agashivala, Neetu, McCague, Kevin, Tenenbaum, Nadia, Edwards, Keith
Publicado 2014

Re-evaluating the treatment of acute optic neuritis

por Bennett, Jeffrey L, Nickerson, Molly, Costello, Fiona, Sergott, Robert C, Calkwood, Jonathan C, Galetta, Steven L, Balcer, Laura J, Markowitz, Clyde E, Vartanian, Timothy, Morrow, Mark, Moster, Mark L, Taylor, Andrew W, Pace, Thaddeus W W, Frohman, Teresa, Frohman, Elliot M
Publicado 2015